昆明医科大学学报2018，Vol.39Issue(5)：128-131,4.
获得性血友病A的治疗进展
Progress in the Treatment of Acquired Hemophilia A
摘要
Abstract
Acquired hemophilia A is a deficiency disease caused by blood coagulation factor Ⅷ antibodies due to a variety of causes, The disease incidence rate is extremely low, but the mortality rate is high. This disease is often misdiagnosed,resulting in delays in treatment, so early diagnosis and timely treatment is crucial for reducing the mortality. The principle of treatment for the disease is mainly to control acute bleeding, eradicate inhibitor, and treat the primary disease,therefore, rational and personalized choices of treatment are also critical.关键词
获得性血友病A/凝血因子Ⅷ/治疗Key words
Acquired hemophilia A/Coagulation factor/Treatment分类
医药卫生引用本文复制引用
林欢,黎承平,吴炳芬,冉立..获得性血友病A的治疗进展[J].昆明医科大学学报,2018,39(5):128-131,4.基金项目
国家自然科学基金资助项目(2015FB049) （2015FB049）
云南省医疗卫生单位内设研究机构科研基金资助项目(2017NS047) （2017NS047）
